Works matching AU Brønden, Andreas

Results: 35

Clinical Pharmacokinetics and Pharmacodynamics of Albiglutide.

Published in:

2017

By:

Brønden, Andreas;
Knop, Filip;
Christensen, Mikkel B.;
Brønden, Andreas;
Knop, Filip K

Publication type:

journal article

Increased gallbladder emptying and reduced GLP‐1 response in pregnancy with and without gestational diabetes mellitus.

Published in:

Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 697, doi. 10.1111/dom.16064

By:

Gether, Ida M.;
Andersen, Emilie S.;
Foghsgaard, Signe;
Ellegaard, Anne‐Marie;
Kelstrup, Louise;
Sonne, David P.;
Brønden, Andreas;
Gillum, Matthew P.;
Holst, Jens J.;
Hartmann, Bolette;
Rehfeld, Jens F.;
Vilsbøll, Tina;
Knop, Filip K.

Publication type:

Article

Elucidating the glucose‐lowering effect of the bile acid sequestrant sevelamer.

Published in:

Diabetes, Obesity & Metabolism, 2024, v. 26, n. 4, p. 1252, doi. 10.1111/dom.15421

By:

Nerild, Henriette H.;
Brønden, Andreas;
Haddouchi, Abdullah E.;
Ellegaard, Anne‐Marie;
Hartmann, Bolette;
Rehfeld, Jens F.;
Holst, Jens J.;
Sonne, David P.;
Vilsbøll, Tina;
Knop, Filip K.

Publication type:

Article

Liraglutide changes postprandial responses of gut hormones involved in the regulation of gallbladder motility.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 6, p. 1632, doi. 10.1111/dom.15017

By:

Nerild, Henriette H.;
Brønden, Andreas;
Gether, Ida M.;
Hellmann, Pernille H.;
Baekdal, Mille;
Gillum, Matthew P.;
Svenningsen, Jens S.;
Hartmann, Bolette;
Rathor, Naveen;
Kudiyanur Muniraju, Hanna Angelene;
Rehfeld, Jens F.;
Holst, Jens J.;
Vilsbøll, Tina;
Sonne, David P.;
Knop, Filip K.

Publication type:

Article

Effects of liraglutide on gallbladder emptying: A randomized, placebo‐controlled trial in adults with overweight or obesity.

Published in:

Diabetes, Obesity & Metabolism, 2018, v. 20, n. 11, p. 2557, doi. 10.1111/dom.13420

By:

Nexøe‐Larsen, Christina C.;
Sørensen, Pernille H.;
Hausner, Helene;
Agersnap, Mikkel;
Baekdal, Mille;
Brønden, Andreas;
Gustafsson, Lea N.;
Sonne, David P.;
Vedtofte, Louise;
Vilsbøll, Tina;
Knop, Filip K.

Publication type:

Article

Glucose‐lowering effects and mechanisms of the bile acid‐sequestering resin sevelamer.

Published in:

Diabetes, Obesity & Metabolism, 2018, v. 20, n. 7, p. 1623, doi. 10.1111/dom.13272

By:

Brønden, Andreas;
Mikkelsen, Kristian;
Sonne, David P.;
Hansen, Morten;
Våben, Christoffer;
Gabe, Maria N.;
Rosenkilde, Mette;
Tremaroli, Valentina;
Wu, Hao;
Bäckhed, Fredrik;
Rehfeld, Jens F.;
Holst, Jens J.;
Vilsbøll, Tina;
Knop, Filip K.

Publication type:

Article

The bile acid‐sequestering resin sevelamer eliminates the acute GLP‐1 stimulatory effect of endogenously released bile acids in patients with type 2 diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2018, v. 20, n. 2, p. 362, doi. 10.1111/dom.13080

By:

Brønden, Andreas;
Albér, Anders;
Rohde, Ulrich;
Gasbjerg, Lærke S.;
Rehfeld, Jens F.;
Holst, Jens J.;
Vilsbøll, Tina;
Knop, Filip K.

Publication type:

Article

Evidence connecting old, new and neglected glucose-lowering drugs to bile acid-induced GLP-1 secretion: A review.

Published in:

Diabetes, Obesity & Metabolism, 2017, v. 19, n. 9, p. 1214, doi. 10.1111/dom.12946

By:

Kårhus, Martin L.;
Brønden, Andreas;
Sonne, David P.;
Vilsbøll, Tina;
Knop, Fillip K.

Publication type:

Article

Short-acting glucagon-like peptide-1 receptor agonists as add-on to insulin therapy in type 1 diabetes: A review.

Published in:

Diabetes, Obesity & Metabolism, 2017, v. 19, n. 7, p. 915, doi. 10.1111/dom.12911

By:

Albèr, Anders;
Brønden, Andreas;
Knop, Filip K.

Publication type:

Article

Involvement of glucagon-like peptide-1 in the glucose-lowering effect of metformin.

Published in:

Diabetes, Obesity & Metabolism, 2016, v. 18, n. 10, p. 955, doi. 10.1111/dom.12697

By:

Bahne, Emilie;
Hansen, Morten;
Brønden, Andreas;
Sonne, David P.;
Vilsbøll, Tina;
Knop, Filip K.

Publication type:

Article

Evaluation of antiseizure medication concentration ranges in blood samples using an automated big data approach.

Published in:

Epilepsia (Series 4), 2025, v. 66, n. 6, p. 1888, doi. 10.1111/epi.18330

By:

Nersesjan, Mariam;
Hoffmann‐Lücke, Elke;
Greibe, Eva;
Aaslo, Per Hersom;
Bak, Lasse Kristoffer;
Pedersen, Lars Engers;
Fruekilde, Palle Bach Nielsen;
Stark, Anette;
Christensen, Jakob;
Brønden, Andreas;
Larsen, Jens Borggaard

Publication type:

Article

Zinc transporter gene expression is regulated by pro-inflammatory cytokines: a potential role for zinc transporters in beta-cell apoptosis?

Published in:

BMC Endocrine Disorders, 2009, v. 9, p. 1, doi. 10.1186/1472-6823-9-7

By:

Egefjord, Lærke;
Jensen, Jens Ledet;
Bang-Berthelsen, Claus Heiner;
Petersen, Andreas Brønden;
Smidt, Kamille;
Schmitz, Ole;
Karlsen, Allan Ertman;
Pociot, Flemming;
himienti, Fabrice;
Rungby, Jørgen;
Magnusson, Nils E.

Publication type:

Article

The zinc transporter ZNT3 co-localizes with insulin in INS-1E pancreatic beta cells and influences cell survival, insulin secretion capacity, and ZNT8 expression.

Published in:

BioMetals, 2016, v. 29, n. 2, p. 287, doi. 10.1007/s10534-016-9915-7

By:

Smidt, Kamille;
Larsen, Agnete;
Brønden, Andreas;
Sørensen, Karen;
Nielsen, Julie;
Praetorius, Jeppe;
Martensen, Pia;
Rungby, Jørgen

Publication type:

Article

Clinical pharmacology of imeglimin for the treatment of type 2 diabetes.

Published in:

Expert Opinion on Pharmacotherapy, 2020, v. 21, n. 8, p. 871, doi. 10.1080/14656566.2020.1729123

By:

Johansson, Karl Sebastian;
Brønden, Andreas;
Knop, Filip Krag;
Christensen, Mikkel Bring

Publication type:

Article

The efficacy and safety of exenatide once weekly in patients with type 2 diabetes.

Published in:

Expert Opinion on Pharmacotherapy, 2019, v. 20, n. 5, p. 501, doi. 10.1080/14656566.2019.1571040

By:

Heimbürger, Sebastian M.;
Brønden, Andreas;
Johansen, Nicklas J.;
Dejgaard, Thomas F.;
Vilsbøll, Tina;
Knop, Filip K.

Publication type:

Article

Exenatide: pharmacokinetics, clinical use, and future directions.

Published in:

Expert Opinion on Pharmacotherapy, 2017, v. 18, n. 6, p. 555, doi. 10.1080/14656566.2017.1282463

By:

Knop, Filip K.;
Brønden, Andreas;
Vilsbøll, Tina

Publication type:

Article

Effects of DPP‐4 inhibitors, GLP‐1 receptor agonists, SGLT‐2 inhibitors and sulphonylureas on mortality, cardiovascular and renal outcomes in type 2 diabetes: A network meta‐analyses‐driven approach.

Published in:

Diabetic Medicine, 2023, v. 40, n. 8, p. 1, doi. 10.1111/dme.15157

By:

Brønden, Andreas;
Christensen, Mikkel Bring;
Glintborg, Dorte;
Snorgaard, Ole;
Kofoed‐Enevoldsen, Allan;
Madsen, Gitte Krogh;
Toft, Katja;
Kristensen, Jette Kolding;
Højlund, Kurt;
Hansen, Troels Krarup;
Søndergaard, Esben;
Hansen, Katrine Bagge

Publication type:

Article

Response to "Advancing understanding of metabolic consequences of cholecystectomy: review reflection".

Published in:

European Journal of Endocrinology, 2024, v. 191, n. 6, p. L11, doi. 10.1093/ejendo/lvae153

By:

Lange, Andreas H;
Pedersen, Miriam G;
Ellegaard, Anne-Marie;
Nerild, Henriette H;
Brønden, Andreas;
Sonne, David P;
Knop, Filip K

Publication type:

Article

Single-Dose Metformin Enhances Bile Acid-Induced Glucagon-Like Peptide-1 Secretion in Patients With Type 2 Diabetes.

Published in:

2017

By:

Brønden, Andreas;
Albér, Anders;
Rohde, Ulrich;
Rehfeld, Jens F;
Holst, Jens J;
Vilsbøll, Tina;
Knop, Filip K

Publication type:

journal article

Cholecystokinin-Induced Gallbladder Emptying and Metformin Elicit Additive Glucagon-Like Peptide-1 Responses.

Published in:

2016

By:

Rohde, Ulrich;
Sonne, David Peick;
Christensen, Mikkel;
Hansen, Morten;
Brønden, Andreas;
Toräng, Signe;
Rehfeld, Jens Frederik;
Holst, Jens Juul;
Vilsbøll, Tina;
Knop, Filip Krag

Publication type:

journal article

The role of glucagon-like peptide 1 in the postprandial effects of metformin in type 2 diabetes: a randomized crossover trial.

Published in:

European Journal of Endocrinology, 2024, v. 191, n. 2, p. 192, doi. 10.1093/ejendo/lvae095

By:

Hansen, Laura S;
Gasbjerg, Lærke S;
Brønden, Andreas;
Dalsgaard, Niels B;
Bahne, Emilie;
Stensen, Signe;
Hellmann, Pernille H;
Rehfeld, Jens F;
Hartmann, Bolette;
Albrechtsen, Nicolai J Wewer;
Holst, Jens J;
Vilsbøll, Tina;
Knop, Filip K

Publication type:

Article

The bile–gut axis and metabolic consequences of cholecystectomy.

Published in:

European Journal of Endocrinology, 2024, v. 190, n. 4, p. R1, doi. 10.1093/ejendo/lvae034

By:

Lange, Andreas H;
Pedersen, Miriam G;
Ellegaard, Anne-Marie;
Nerild, Henriette H;
Brønden, Andreas;
Sonne, David P;
Knop, Filip K

Publication type:

Article

The Body weight Reducing Effects of Tirzepatide in People with and without Type 2 Diabetes: A Review on Efficacy and Adverse Effects.

Published in:

Patient Preference & Adherence, 2024, v. 18, p. 373, doi. 10.2147/PPA.S419304

By:

Jensen, Thomas Leth;
Brønden, Andreas;
Karstoft, Kristian;
Sonne, David Peick;
Christensen, Mikkel Bring

Publication type:

Article

Cardiovascular safety and benefits of GLP-1 receptor agonists.

Published in:

Expert Opinion on Drug Safety, 2017, v. 16, n. 3, p. 351, doi. 10.1080/14740338.2017.1281246

By:

Dalsgaard, Niels B.;
Brønden, Andreas;
Vilsbøll, Tina;
Knop, Filip K.

Publication type:

Article

Preclinical discovery and development of colesevelam for the treatment of type 2 diabetes.

Published in:

Expert Opinion on Drug Discovery, 2018, v. 13, n. 12, p. 1161, doi. 10.1080/17460441.2018.1538206

By:

Nerild, Henriette Holst;
Christensen, Mikkel Bring;
Knop, Filip Krag;
Brønden, Andreas

Publication type:

Article

SLC30A3 Responds to Glucose- and Zinc Variations in ß- Cells and Is Critical for Insulin Production and In Vivo Glucose-Metabolism During ß-Cell Stress.

Published in:

PLoS ONE, 2009, v. 4, n. 5, p. 1, doi. 10.1371/journal.pone.0005684

By:

Smidt, Kamille;
Jessen, Niels;
Petersen, Andreas Brønden;
Larsen, Agnete;
Magnusson, Nils;
Jeppesen, Johanne Bruun;
Stoltenberg, Meredin;
Culvenor, Janetta G.;
Tsatsanis, Andrew;
Brock, Birgitte;
Schmitz, Ole;
Wogensen, Lise;
Bush, Ashley I.;
Rungby, Jørgen

Publication type:

Article

Single-Dose Metformin Enhances Bile Acid–Induced Glucagon-Like Peptide-1 Secretion in Patients With Type 2 Diabetes.

Published in:

Journal of Clinical Endocrinology & Metabolism, 2017, p. 4153, doi. 10.1210/jc.2017-01091

By:

Brønden, Andreas;
Albér, Anders;
Rohde, Ulrich;
Rehfeld, Jens F.;
Holst, Jens J.;
Vilsbøll, Tina;
Knop, Filip K.

Publication type:

Article

770-P: The Glucose-Lowering Effect of the Bile Acid Sequestrant Sevelamer Is Not Mediated by Glucagon-Like Peptide-1.

Published in:

Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-770-P

By:

NERILD, HENRIETTE H.;
BRØNDEN, ANDREAS;
SONNE, DAVID P.;
HOLST, JENS J.;
VILSBØLL, TINA;
KNOP, FILIP K.

Publication type:

Article

103-OR: The Glucagon-Like Peptide-1 Analog, Liraglutide Is a Safe and Effective Treatment of Bile Acid Malabsorption: A Proof of Concept Study.

Published in:

Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-103-OR

By:

KÅRHUS, MARTIN L.;
BRØNDEN, ANDREAS;
FORMAN, JULIE;
HAABER, ANNE;
LANGHOLZ, EBBE;
VILSBØLL, TINA;
SONNE, DAVID P.;
KNOP, FILIP K.

Publication type:

Article

1662-P: Lower Expression of Bile Acid Transporters and Fibroblast Growth Factor 19 in Mucosa Biopsies from the Ileocecal Region in Persons with Type 2 Diabetes Compared with Healthy Controls.

Published in:

Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1662-P

By:

NERILD, HENRIETTE H.;
BRØNDEN, ANDREAS;
HADDOUCHI, ABDULLAH EL;
JORSAL, TINA;
SONNE, DAVID P.;
JELSING, JACOB;
RIGBOLT, KRISTOFFER;
VILSBØLL, TINA;
KNOP, FILIP K.

Publication type:

Article

23-OR: The Effect of 14-Day Atorvastatin Treatment on Postprandial Glucose Metabolism in Healthy Males—A Link to Why Statin Therapy Increases the Risk of Type 2 Diabetes?

Published in:

Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-23-OR

By:

THOMASEN, MARTIN L.;
SONNE, DAVID P.;
KÅRHUS, MARTIN L.;
BRØNDEN, ANDREAS;
STAELS, BART;
HOLST, JENS J.;
VILSBØLL, TINA;
KNOP, FILIP K.

Publication type:

Article

1982-P: Glucagon-Like Peptide-2 Inhibits Postprandial Gallbladder Emptying in Healthy Male Individuals—A Randomized, Double-Blinded, Placebo-Controlled Study.

Published in:

Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1982-P

By:

HANSEN, NINA L.;
NEXØE-LARSEN, CHRISTINA CHARLOTTE;
BRØNDEN, ANDREAS;
CHRISTENSEN, ALEXANDER S.;
SONNE, DAVID P.;
HARTMANN, BOLETTE;
VILSBØLL, TINA;
HOLST, JENS J.;
KNOP, FILIP K.

Publication type:

Article

1980-P: A Characterization of Postprandial Glucose Metabolism and Incretin Hormone Responses in Patients with Bile Acid Malabsorption.

Published in:

Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1980-P

By:

KÅRHUS, MARTIN L.;
SONNE, DAVID P.;
THOMASEN, MARTIN L.;
HOLST, JENS J.;
VILSBØLL, TINA;
BRØNDEN, ANDREAS;
KNOP, FILIP K.

Publication type:

Article

Expression of Bile Acid Receptors and Transporters Along the Intestine of Patients With Type 2 Diabetes and Controls.

Published in:

Journal of Clinical Endocrinology & Metabolism, 2025, v. 110, n. 3, p. e660, doi. 10.1210/clinem/dgae261

By:

Nerild, Henriette H;
Gilliam-Vigh, Hannah;
Ellegaard, Anne-Marie;
Forman, Julie L;
Vilsbøll, Tina;
Sonne, David P;
Brønden, Andreas;
Knop, Filip K

Publication type:

Article

Gluco-Metabolic Effects of Pharmacotherapy-Induced Modulation of Bile Acid Physiology.

Published in:

2019

By:

Brønden, Andreas;
Knop, Filip K

Publication type:

journal article